Purpose of review
To describe the pathology, impact of comorbidities, functional
limitations, symptoms, and quality of life (QOL) related to treatment of
acute myeloid leukemia (AML) in older adults.
Recent findings
AML is a rare aggressive hematologic disease that occurs most often
in older adults. The prognosis for older patients with AML is markedly worse
due to genetic mutations and patient characteristics such as comorbidities
and functional limitations. Patient characteristics may influence treatment
decisions, as well as impact symptoms, functional ability, health-related
outcomes and (QOL).
Summary
As the population continues to age, the number of people diagnosed
with AML is expected to increase. Better management of comorbidities is
imperative to improving QOL and other treatment related outcomes.
Prospective, longitudinal and multi-site studies are warranted to further
understand the interaction between these characteristics on symptoms,
outcomes and QOL.